Correspondence

Barriers to research beyond cannabinoids: call for evidence

Barriers to Research working group calls for written evidence about barriers to legitimate research for controlled drugs, excluding synthetic cannabinoids.

• From: Advisory Council on the Misuse of Drugs
• Published: 19 March 2021
• Last updated: 22 April 2021 — See all updates

Documents

Call for evidence: barriers to research beyond cannabinoids

MS Word Document, 96.7 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Further to the call for evidence issued in February 2020 regarding barriers to legitimate research on 3rd generation synthetic cannabinoids, the ACMD Barriers to Research working group would like to issue a second call to researchers to help in their formulation of advice to government. This time the ACMD would like researchers to look beyond synthetic cannabinoids, and provide evidence on barriers to legitimate research on all controlled drugs.

The deadline, which has been extended, to provide written feedback using the attached questionnaire is now 31 May 2021. Please return your submission to [email protected].

We are extending the deadline for the call for evidence.

This questionnaire is not in an accessible format. If you need help completing it or are unable to use Microsoft Word please email [email protected].

Published 19 March 2021
Last updated 22 April 2021 + show all updates

1. 22 April 2021

   The call for evidence on barriers to research beyond cannabinoids has been extended to 31 May 2021.

2. 19 March 2021

   First published.